Aims/hypothesis We studied the associations of size at birth and prematurity with type 2 diabetes, insulin sensitivity and beta cell function in the Danish population-based Inter99 study (ClinicalTrials.gov NCT00289237). Methods Information about size at birth and prematurity was identified from original midwife records in 4,744 middle-aged Danes. Type 2 diabetes status, insulin sensitivity (Matsuda index) and beta cell function (disposition index) were assessed using a 75 g oral glucose tolerance test. Participants born prematurely were compared with a group of at-term participants born small for gestational age.
Introduction
Low birthweight has previously been associated with type 2 diabetes [1, 2] . However, only few studies have examined this association in a random sample of the population and used an OGTT to diagnose type 2 diabetes. Reduced insulin sensitivity has been reported to be a mediator between low birthweight and type 2 diabetes [2, 3] , while beta cell dysfunction has been associated with low birthweight in some [1] but not all studies [2] .
Beside low birthweight, prematurity as such has been associated with reduced insulin sensitivity in young patients [4] . A recent Swedish register-based study reported that prematurity was associated with an increased risk of type 2 diabetes independently of birthweight [5] .
We aimed to examine the associations between both size at birth and prematurity, and the risk of type 2 diabetes in a Danish study sample. We also examined the extent to which birthweight and/or prematurity are associated with insulin sensitivity and/or beta cell function.
Methods

Study background
The Inter99 study is a Danish intervention study aimed at reducing the incidence of ischaemic heart disease and type 2 diabetes [6] (www.Inter99.dk, accessed 7 September 2010). From a population-based sample (n=61,301) of 30-to 60-year-old individuals, a random sample of 13,016 was invited. The participation rate was 52.5% (n=6,784). We used data from the baseline examinations, which were performed from 1999 to 2001. Participants gave written informed consent prior to inclusion. The protocol was in accordance with the Helsinki Declaration, approved by the local ethics committee (KA98155) and registered with ClinicalTrials.gov (NCT00289237).
Participants completed a self-administered questionnaire on health, socioeconomic factors, lifestyle and maternal/paternal diabetes status (yes/no/unknown). Lifestyle variables included physical activity, diet, alcohol consumption and smoking. After an overnight fast, a 75 g OGTT was performed. Venous samples for measurement of plasma glucose and serum insulin concentrations were taken at 0, 30 and 120 min and analysed as previously described [6] . Type 2 diabetes was diagnosed according to the WHO 1999 criteria [7] .
Midwife records of 4,744 participants were identified as previously described [8] . Ponderal index, i.e. birthweight (kg)/length(m 3 ), was calculated as a measure of infant body composition. We included 4,644 participants born as singletons and without type 1 diabetes in this study.
Prematurity Participants born prematurely (before week 37) were compared with a group of singletons born at term (weeks 37-42) and matched for birthweight; this group was referred to as small for gestational age (SGA). The remaining participants born at term were considered appropriate for gestational age. Detailed information on gestational age was available in 363 of the 443 participants born prematurely and fetal growth rates were assessed using birthweight z-scores, calculated as: (birthweight-normal birthweight for gestational age)/SD of normal birthweight. A Swedish reference curve for normal weight was used [9] .
Insulin sensitivity and beta-cell function Insulin sensitivity was assessed by HOMA of insulin sensitivity (1/HOMA of insulin resistance [10] ) and a modified Matsuda index [11] . Areas under the curve for plasma glucose and serum insulin were calculated using a trapezoidal method. Beta cell function (disposition index) was assessed as the product of insulin secretion (AUC insulin /AUC glucose ) and insulin sensitivity (modified Matsuda index). Participants with known type 2 diabetes were excluded from the analysis of insulin sensitivity, insulin secretion and beta cell function.
Statistical analysis
The association between birthweight and measures of glucose regulation and type 2 diabetes was investigated in four steps. Model 1 adjusted for age and sex. Model 2 additionally adjusted for adult BMI. Model 3 additionally adjusted for maternal parity and parental diabetes status, with missing or 'unknown' information on parental diabetes treated as 'no diabetes'. Model 4 further adjusted for socioeconomic factors and lifestyle variables (physical activity, diet, alcohol consumption and smoking).
Risk of type 2 diabetes was assessed by logistic regression analysis. Multivariate linear regression analyses were performed to study the relationship between birthweight or prematurity and OGTT-derived measures of glucose regulation. The outcome variables presented in Table 1 were log e -transformed to meet the assumption of normality. Results are in percentage change per 1,000 g increase in birthweight. We did not use correction for multiple testing, as our work was based on the predefined rationale of a potential association between low birthweight and prematurity, and (1) type 2 diabetes, (2) reduced insulin sensitivity and (3) beta cell dysfunction as previously described. SAS version 9.1 (SAS Institute, Cary, NC, USA) was used for statistical analysis.
Results
In this random sample of Danes, 69% (n=154) of diabetes cases were screen-detected; the prevalence of type 2 diabetes was 6.5% for men and 3.8% for women.
An increase in birthweight of 1 kg was associated with a 51% (OR 0.49; 95% CI 0.35-0.69; p<0.001) lower risk of type 2 diabetes after adjusting for age, sex and BMI (Table 1) . Adjustment for socioeconomic factors and lifestyle variables did not alter this observation. Supplementary analyses performed only on complete cases or using simple imputation of missing values for socioeconomic factors and lifestyle variables also did not change the observations (data not shown).
A 1 SD (2.28 kg/m 3 ) increase in ponderal index was associated with a 23% (OR 0.77; 95% CI 0.64-0.92; p<0.01) reduction in the risk of type 2 diabetes as compared with a 27% (OR 0.73; 95% CI 0.61-0.87; p<0.001) risk reduction related to an increase in birthweight of 1 SD (451 g).
Birthweight was positively related to insulin sensitivity (Table 1) . Despite an inverse relationship between birthweight and insulin release, birthweight showed a positive relationship with beta cell function, reflected by the disposition index (Table 1) .
The participants born prematurely had a higher ponderal index at birth than SGA participants (Table 2) . Despite this discrepancy, the two groups had similarly increased prevalence of type 2 diabetes and a similar degree of post-load hyperglycaemia, hyperinsulinaemia and insulin resistance. The OR for type 2 diabetes was 1.79 (95% CI 1.17-2.74) for premature participants compared with participants born at term (SGA+appropriate for gestational age; p=0.007). Birthweight z-scores, reflecting fetal growth rates, were not related to risk of type 2 diabetes or measures of glucose regulation among participants born prematurely (data not shown).
Discussion
Using a random cohort and a clinical assessment of glucose regulation and type 2 diabetes, this study demonstrates that low birthweight and prematurity are associated with increased risk of type 2 diabetes, supporting a recent registry-based study [5] . It also documents that low birthweight is associated with beta cell dysfunction and reduced insulin sensitivity, whereas prematurity is associated solely with attenuated insulin sensitivity.
As for the other end of the birthweight spectrum, elevated birthweight has been associated with type 2 diabetes in some [12] but not all previous studies [1, 2] . The lack of a significant relation between high birthweight and type 2 diabetes in this study may theoretically be explained by a low frequency of gestational diabetes among the mothers. Ponderal index, a measure of thinness at birth, has previously been proposed to be a stronger predictor of type 2 diabetes than birthweight [2] . However, our finding of a quantitatively similar risk of type 2 diabetes for birthweight and ponderal index neither supports that notion nor the idea that ponderal index is a superior marker of an adverse intrauterine environment.
The robustness of our findings is illustrated by the consistency of the results across the four applied levels of adjustment. The finding that the associations between birthweight and risk of type 2 diabetes remained similar after adjusting for maternal parity and parental diabetes status (model 3), as well as socioeconomic and lifestyle factors (model 4), may be explained by the magnitude of findings for age and BMI, which are included in model 1 and 2, respectively.
Originally, beta cell dysfunction was thought to represent a key link between low birthweight and the risk of type 2 diabetes [1] . However, subsequent studies reported low birthweight to be associated with reduced insulin sensitivity rather than decreased insulin secretion [13] . Our participants with low birthweight had elevated concentrations of post-load serum insulin, but when accounting for insulin sensitivity, their beta cell function was in fact reduced. The necessity of adjusting for insulin sensitivity may be particularly important in relatively young study populations like that of the Inter99 study, as hyperinsulinaemia and reduced insulin sensitivity precede pancreatic failure in absolute terms in the natural history of type 2 diabetes.
Despite less disproportionate fetal growth, reflected by a higher ponderal index at birth, participants born prematurely had a similar reduction of insulin sensitivity as well as a similarly elevated risk of type 2 diabetes compared with participants born SGA. Interestingly, no association between birthweight z scores and type 2 diabetes or other measures of glucose regulation was observed among the participants born prematurely, and prematurity was not associated with reduced beta cell function. Altogether, our results suggest that the early life programming mechanisms that mediate the increased risk of type 2 diabetes may be different for low birthweight and prematurity. The Inter99 study is based on an age-and sex-stratified random sample of the population. As in all populationbased studies, it faces selection bias towards more healthy individuals among participants compared with nonparticipants [6] . Moreover, the prevalence of type 2 diabetes was slightly lower among Inter99 participants with traced midwife records vs those without traced midwife records [8] . If anything, this selection bias towards inclusion of the healthiest segment of the Danish middleaged population may have led to underestimation of the reported effects of perinatal factors in the aetiology of type 2 diabetes.
In conclusion, we found both reduced insulin sensitivity and beta cell dysfunction to be mediators in the association between low birthweight and type 2 diabetes. In addition, prematurity was associated with attenuated insulin sensitivity and type 2 diabetes independently of fetal growth rate.
